Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI.
Brembilla G, Basile G, Cosenza M, Giganti F, Del Prete A, Russo T, Pennella R, Lavalle S, Raggi D, Mercinelli C, Tateo V, Cigliola A, Patanè D, Crupi E, Giannatempo P, Messina A, Calareso G, Martini A, Bandini M, Moschini M, Cardone G, Briganti A, Montorsi F, Necchi A, De Cobelli F. Brembilla G, et al. Among authors: tateo v. Radiology. 2024 Dec;313(3):e233020. doi: 10.1148/radiol.233020. Radiology. 2024. PMID: 39718497 Clinical Trial.
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review.
Crupi E, Costa de Padua T, Marandino L, Fallara G, Pederzoli F, Cimadamore A, Goetz EC, Cigliola A, Patané DA, Mercinelli C, Tateo V, Salonia A, Briganti A, Montorsi F, Meeks JJ, Spiess PE, Alhalabi O, Gao J, Kamat AM, Grivas P, Necchi A, Raggi D. Crupi E, et al. Among authors: tateo v. JCO Precis Oncol. 2024 Dec;8:e2400470. doi: 10.1200/PO-24-00470. Epub 2024 Dec 3. JCO Precis Oncol. 2024. PMID: 39626158 Review.
Epidemiology and Risk Factors for Testicular Cancer: A Systematic Review.
Tateo V, Thompson ZJ, Gilbert SM, Cortessis VK, Daneshmand S, Masterson TA, Feldman DR, Pierorazio PM, Prakash G, Heidenreich A, Albers P, Necchi A, Spiess PE. Tateo V, et al. Eur Urol. 2024 Nov 13:S0302-2838(24)02685-X. doi: 10.1016/j.eururo.2024.10.023. Online ahead of print. Eur Urol. 2024. PMID: 39542769 Review.
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer.
Mercinelli C, Moschini M, Cigliola A, Mattorre B, Tateo V, Basile G, Cogrossi LL, Maiorano BA, Patanè DA, Raggi D, Pastorino GL, Re C, Colecchia M, Lucianò R, Colombo R, Brembilla G, De Cobelli F, Briganti A, Pavlick DC, Ross JS, Montorsi F, Bellone M, Necchi A. Mercinelli C, et al. Among authors: tateo v. J Clin Oncol. 2024 Dec 10;42(35):4196-4205. doi: 10.1200/JCO.24.00576. Epub 2024 Sep 6. J Clin Oncol. 2024. PMID: 39241203 Clinical Trial.
Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel.
Tateo V, Cigliola A, Mercinelli C, Agarwal N, Grivas P, Kamat AM, Gibb EA, Moschini M, Brausi M, Dyrskjøt L, Loriot Y, Gupta S, Colecchia M, Spiess PE, Ross JS, Necchi A. Tateo V, et al. Clin Genitourin Cancer. 2024 Aug;22(4):102091. doi: 10.1016/j.clgc.2024.102091. Epub 2024 Apr 10. Clin Genitourin Cancer. 2024. PMID: 38735133
Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer.
Li R, Nocera L, Rose KM, Raggi D, Naidu S, Mercinelli C, Cigliola A, Tateo V, Patanè D, Grass GD, Gilbert SM, Sexton WJ, Bandini M, Moschini M, Briganti A, Montorsi F, Spiess PE, Necchi A. Li R, et al. Among authors: tateo v. Eur Urol Oncol. 2024 Jun;7(3):614-624. doi: 10.1016/j.euo.2023.12.008. Epub 2024 Jan 6. Eur Urol Oncol. 2024. PMID: 38184473
28 results